Preparation and in-vitro evaluation of PCL–PEG–PCL nanoparticles for doxorubicin-ezetimibe co-delivery against PC3 prostate cancer cell line

Volume 7, Issue 2, March 2024, Pages 159-172

10.22034/crl.2024.436907.1285

Mina Yousefnezhad; Mirzaagha Babazadeh; Soodabeh Davaran; Abolfazl Akbarzadeh; Hamidreza Pazoki-Toroudi

• View Article
• PDF 1.25 M